Nicotinamide adénine dinucléotide réduite in food supplements
175 supplements declared in France contain Nicotinamide adénine dinucléotide réduite as a substance or active ingredient.
Other names in the Compl'Alim list: NADH.
Compl'Alim declarations. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
In plain words
À quoi il sert, selon les fabricants
Objectives most often stated for supplements that contain it (Nicotinamide adénine dinucléotide réduite): antioxydant (19 produits), mémoire (13 produits), peau (12 produits), sport (10 produits), immunité (9 produits).
These are the objectives manufacturers declared to the authorities, not proven effects. On the packaging, only health claims authorised by the EU may be written.
Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared daily quantities
| Unit | Products | Median | Minimum | Maximum |
|---|---|---|---|---|
| mg | 77 | 20 | 1 | 1,000 |
Calculated from Compl'Alim declarations that provide a quantity. These are quantities declared by manufacturers, not measurements, and preparation is not distinguished (powder, extract of varying concentration): differences between products can be very large.
What the registers say, country by country
Each line repeats what an official register says on the date it was consulted. Not being in a register means neither allowed nor banned.
Compl'Alim ingredient list (France): listed.
Compl'Alim, reference list of ingredients, retrieved 21 October 2026.
United States, supplement labels (DSLD; supplements need no prior approval): 29 products.
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Poland, notified supplements: 15 products.
GIS, products notified in Poland, retrieved 27 October 2026.
Główny Inspektorat Sanitarny (GIS), Rejestr produktów objętych powiadomieniem
What we know about this ingredient
Scientific publications (PubMed)
5,341 records published in the five years before 12 November 2026. The name is searched in the title or abstract; derivatives and passing mentions can be counted. This count does not measure effectiveness.
Searched on 12 November 2026.
Most recent systematic reviews and meta-analyses:
- PMID 42952324. Energetic metabolism in bipolar disorder: from markers to precision therapeutics. (2026, Acta neuropsychiatrica)
- PMID 42774067. Domain-specific effects of NAD(+) precursors on fatigue and functional performance: a systematic review and network meta-analysis. (2026, Frontiers in nutrition)
- PMID 42968057. Mitochondrial Haplogroup U and multiple sclerosis risk in Arab and Near Eastern populations: a systematic review and meta-analysis. (2026, BMC neurology)
Products
- NADH+ gélule, declared in 2018
- NADH+ gélule, declared in 2024
- NADH, 10mg NOW Foods, gélule, declared in 2025
- NADivitB3 Nutritys, gélule, declared in 2023
- NEUROPLASTINE + Lisarce, gélule, declared in 2026
- NMN15000 PRONUTRI, gélule, declared in 2024
- NUCLEOXINE + Lisarce, gélule, declared in 2026
- Neuroplastine Bivea, gélule, declared in 2019
- Nicotinamide Adénine Dinucléotide Klotho health and research, gélule, declared in 2025
- Nutri MAX-32 CELL'INNOV, gélule, declared in 2022
- PANMOL® NADH HSN, capsule, declared in 2022
- PHYSIOFORM SFB, gélule, declared in 2019
- PREMIUM GUMMIES NADH + BEAUTY PROBIOTICS® gomme, declared in 2026
- PROSUPPS - NAD+ gélule, declared in 2025
- Premium Trans-Resvératrol Zenement, capsule, declared in 2024
- Prof. George Birkmayer NADH Constant Prof. George Birkmayer NADH GmbH, comprimé, declared in 2023
- Prof. George Birkmayer NADH® Arthros capsule, declared in 2023
- Prof. George Birkmayer NADH® Vision capsule, declared in 2023
- Prof. George Birkmayer NADH®Rapid Prof. George Birkmayer NADH®, comprimé, declared in 2020
- Q10 Révolution Cell'innov, gélule, declared in 2025
- RESVERATROL + NAD Dieti natura, gélule, declared in 2026
- REVITAL capsule, declared in 2024
- Rejuv'Activ NR&D, gélule, declared in 2024
- Rejuv'activ NR&D, gélule, declared in 2026
- Restore HUMAN BY NATURE, gélule, declared in 2023
- SEPTIFERRINE + Lisarce, gélule, declared in 2026
- SPORT PERFORMANCE VIT'ALL +, gélule, declared in 2022
- SYNERMEMORY gélule, declared in 2026
- Seregold gélule, declared in 2023
- Sublingual NADH 20mg fair&pure, comprimé, declared in 2026
- TELOREGEN gélule, declared in 2019
- TRANS RESVERATROL + NAD ALPSNATURE, gélule, declared in 2025
- TRANS-RESVERATROL & NAD+ COMPLEX NUTRALIE, gélule, declared in 2025
- TRANS-RESVÉRATROL 1000 MG AVEC NAD+ NUTRABETTER, gélule, declared in 2025
- Tonus CELL'INNOV, gélule, declared in 2017
- Trans-Resveratrol & NAD+ avec Huile d'Olive Vierge Extra Bio capsule, declared in 2024
- Ultyma BIOVANCIA, gélule, declared in 2026
- VITA B COMPLEX Inovance, gélule, declared in 2021
- WeightWorld Liposomal NAD+ with Resveratrol 600mg 90 Capsules gélule, declared in 2025
- nucleoxine BIVEA, gélule, declared in 2018
- nucleoxine 80 Lisarce, gélule, declared in 2018
- septiferrine Bivea, gélule, declared in 2020
- thyroïde thefitgarden, capsule, declared in 2018
- Actifolic gélule, earlier declaration, replaced by the 2022 declaration
- Deep Boost flacon, withdrawn from the market
- Immune + Fit & Healthy, gélule, withdrawn from the market
- Intelectio capsule, withdrawn from the market
- Multi-Activ gélule, declaration 297861, withdrawn from the market
- Multi-Activ gélule, declaration 299521, withdrawn from the market
- Multi-Activ gélule, declaration 313798, withdrawn from the market
- NADH Api Nature, gélule, withdrawn from the market
- NADH NutriLife, gélule, withdrawn from the market
- NADH 50 mg Vitality Nutritionals, capsule, earlier declaration, replaced by the 2026 declaration
- NADivitB3 Nurilia, gélule, declaration 151994, withdrawn from the market
- NADivitB3 Nurilia, gélule, declaration 232181, withdrawn from the market